Biocon's Q2 profits down 12% on higher R&D expenses, forex losses

Higher R&D expenses, staff costs and forex losses have dragged Biocon's profits (before exceptional item & discontinuing operations) by 12 per

from Business Line - Companies https://ift.tt/3olmA6s